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Abstract
Metabolic feedback between the gut and the brain relayed via the vagus nerve contributes to energy homeostasis. We investigated in healthy adults whether noninvasive stimulation of vagal afferents impacts energy homeostasis via efferent effects on metabolism or digestion. In a randomized crossover design, we applied transcutaneous auricular vagus nerve stimulation (taVNS) while recording efferent metabolic effects using simultaneous electrogastrography (EGG) and indirect calorimetry. We found that taVNS reduced gastric myoelectric frequency (p = .008), but did not alter resting energy expenditure. We conclude that stimulating vagal afferents induces gastric slowing via vagal efferents without acutely affecting net energy expenditure at rest. Collectively, this highlights the potential of taVNS to modulate digestion by activating the dorsal vagal complex. Thus, taVNS-induced changes in gastric frequency are an important peripheral marker of brain stimulation effects.
Introduction
Maintaining energy homeostasis is vital for organisms and necessitates a balance between energy intake and expenditure [1] . Achieving this balance requires vagal afferents to transmit information between peripheral organs and the dorsal vagal complex in the brain stem [2] [3] [4] [5] [6] . Invasive stimulation of the vagus nerve (VNS) as well as the more recent non-invasive transcutaneous auricular VNS (taVNS, [7] [8] [9] ) impact energy homeostasis by modulating food intake, energy metabolism, and glycemic control [10] [11] [12] . In rodents, VNS triggered by phasic stomach contractions resulted in weight loss [13] . In humans, taVNS led to a decreased frequency and increased amplitude of gastric motility [14] . Such metabolic effects might be related to VNSinduced increases in the activity of brown adipose tissue, which in turn increased the basal metabolic rate [15] . Notably, dopamine has been suggested as a neuromodulator of energy homeostasis within the gut-brain axis [16, 17] . Afferently, stimulation of the vagal sensory ganglion in mice was found to induce dopamine release in the substantia nigra [17] . Efferently, dopamine administration to the dorsal vagal complex in rats modulated the upper gastrointestinal tract by reducing gastric tone and motility via DA2 receptors in the dorsal motor nucleus of the vagus [18] . Thus, while vagal stimulation mostly targets afferent pathways, studies in rodents provide evidence for brain-mediated effects on downstream targets.
Although there is preliminary evidence linking vagal signaling and energy homeostasis [14] , efferent taVNS-induced effects on digestion and energy metabolism in healthy humans have not been conclusively demonstrated. We therefore investigated whether taVNS vs. sham changes electrogastrography (EGG) and indirect calorimetry as markers of energy homeostasis. After a resting period of at least 15 minutes, we recorded a 15-minute baseline for both EGG and calorimetry. Next, we placed the taVNS device on the participants' left ear according to the randomization protocol. The individual stimulation intensity was adjusted based on subjective pain thresholds using concurrent VAS ratings (for details, see [20] ). We then recorded at least 30 minutes of EGG and calorimetry during active stimulation before the participant was debriefed.
Data preprocessing and statistical analysis
EGG data were preprocessed and inspected for muscle artifacts. We then identified the gastric peak frequency for baseline, taVNS and sham, respectively, based on spectral density for each EGG channel (see SI). One participant had to be excluded after quality control due to absence of visibly identifiable peaks in any channel in both sessions, leaving N=21 for the statistical analysis.
We calculated baseline-corrected delta mean gastric frequency (in mHz) by subtracting the individual session-specific baseline mean gastric frequency from the respective taVNS and sham mean gastric frequency. Next, we calculated the net effect of stimulation (interaction) by subtracting delta sham from delta taVNS. After preprocessing the calorimetry data (see SI), we calculated the same measures for REE (in kcal/day). For non-parametric inference, we bootstrapped the distribution of taVNS-induced changes in gastric frequency and REE, respectively, using 50,000
repetitions and calculated two-tailed p-values.
Results
We found that taVNS compared to sham led to a significant reduction in gastric myoelectric frequency ( Figure 1A; 
Discussion
In line with the hypothesized efferent effect, we found that taVNS alters a marker of energy homeostasis in humans. The observed taVNS-induced reduction in gastric frequency is well in line with previous findings linking VNS to altered energy homeostasis [13, 14, 17] . This efferent effect on gastric motility might be due to a taVNS-induced release of dopamine in the brain stem. Previous work has shown that elevated levels of brain stem dopamine lead to reduced food intake [21] and gastric relaxation [22] . Moreover, dopamine administration in the brain stem reduced gastric tone and motility which was abolished by vagotomy [18] . Studies linking alterations in vagal signaling to the development of Parkinson's disease [23, 24] further support the assumption of afferent signaling between the gut and key dopaminergic brain regions along the vagal pathway. Therefore, taVNS-induced neuromodulation in the brain stem might lead to the observed slowing of gastric myoelectric frequency via the efferent vagal pathway.
In contrast to chronic VNS in patients [15] , we did not find changes in energy expenditure during acute taVNS. This pattern indicates that compared to changes in digestion taVNS-induced effects on energy expenditure may develop across longer time periods.
In sum, we demonstrated that taVNS reduces gastric frequency without affecting REE. This shows that transcutaneous stimulation of vagal afferents can elicit efferent gastric effects through a feedback loop via the dorsal vagal complex. Thus, in light of the heterogeneous efferent effects of taVNS on electrocardiogram parameters [25, 26] , the EGG may be a promising positive control measure for taVNS in healthy humans [27] . 
